From Actavis website
Actavis is one of the world’s leading players in the development, manufacture, and sale of first-class generic pharmaceuticals. The successful integration of a number of acquisitions has helped position Actavis among the world’s largest companies in the industry. Founded in 1956, the Group has more than 10,000 employees operating in over 40 countries around the globe. Actavis’ headquarters are in Iceland.
Board of Directors:
Thor Bjorgolfsson is the largest shareholder in Actavis. He has been a member of the Actavis Board since 1999 and Chairman since 2000.
An entrepreneur and international investor living in the UK, Thor is the founder of the London investment firm Novator. His other interests are mainly in telecommunication.
Since 2005 Thor has been selected as a Young Global Leader of the World Economic Forum which holds its annual meeting in Davos, Switzerland. He is also a member of the board of the EastWest Institute, a leading policy think tank addressing regional and global challenges.
Sigurgeir Gudlaugsson joined the Actavis Board in 2008. He currently runs his own consulting company, Citalfort Consulting, providing independent strategic and financial advisory services to investors and corporates.
Before establishing Citalfort Consulting, Sigurgeir was Managing Director of Novator Healthcare. He was previously Head of Mergers & Acquisitions of the Actavis Group and was responsible for the Group’s global M&A activity. He holds a degree in International Business from the Copenhagen Business School and has broad experience in healthcare and banking.
Sigurdur Oli Olafsson
Sigurdur Oli Olafsson is the CEO of Actavis Group. He joined Actavis in 2003, after working for Pfizer UK from 1998 and moving to Pfizer US in 2001 to take a post in Global Research and Development. Prior to that, he served as Marketing Manager of Omega Farma (now Actavis), later becoming its Drug Development Manager.
Sigurdur became the Managing Director of Actavis Inc. in the US in 2003. He became Chief Executive of Corporate Development in 2004 and Chief Executive of Sales & Marketing International in 2005. He was Deputy to the CEO 2006-2008. Sigurdur holds a degree in Pharmacy from the University of Iceland.